Pfizer
PFE
PFE
1,959 hedge funds and large institutions have $144B invested in Pfizer in 2016 Q3 according to their latest regulatory filings, with 75 funds opening new positions, 885 increasing their positions, 762 reducing their positions, and 81 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 1,988 → 1,959 (-29)
5% less capital invested
Capital invested by funds: $152B → $144B (-$8.2B)
18% less funds holding in top 10
Funds holding in top 10: 286 → 234 (-52)
Holders
1,959
Holding in Top 10
234
Calls
$2.25B
Puts
$2.33B
Top Buyers
| 1 | +$337M | |
| 2 | +$327M | |
| 3 | +$270M | |
| 4 |
Renaissance Technologies
New York
|
+$231M |
| 5 |
JP Morgan Chase
New York
|
+$176M |
Top Sellers
| 1 | -$747M | |
| 2 | -$548M | |
| 3 | -$272M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$263M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$249M |